MassMutual Private Wealth & Trust FSB Boosts Stake in DENTSPLY SIRONA Inc. $XRAY

MassMutual Private Wealth & Trust FSB boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 160.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,805 shares of the medical instruments supplier’s stock after purchasing an additional 1,727 shares during the period. MassMutual Private Wealth & Trust FSB’s holdings in DENTSPLY SIRONA were worth $45,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of XRAY. Ameriprise Financial Inc. grew its position in DENTSPLY SIRONA by 10.2% in the 4th quarter. Ameriprise Financial Inc. now owns 249,246 shares of the medical instruments supplier’s stock valued at $4,735,000 after acquiring an additional 23,053 shares during the last quarter. Deutsche Bank AG grew its position in DENTSPLY SIRONA by 29.7% in the 4th quarter. Deutsche Bank AG now owns 15,720 shares of the medical instruments supplier’s stock valued at $298,000 after acquiring an additional 3,603 shares during the last quarter. Point72 Asset Management L.P. bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $179,000. Tidal Investments LLC grew its position in DENTSPLY SIRONA by 15.5% in the 4th quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier’s stock valued at $488,000 after acquiring an additional 3,449 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in DENTSPLY SIRONA by 13.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock valued at $10,466,000 after acquiring an additional 65,308 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research reports. Barrington Research lowered their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. UBS Group lowered their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, August 8th. Finally, Stifel Nicolaus lowered their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $18.64.

DENTSPLY SIRONA Trading Down 1.9%

Shares of NASDAQ:XRAY opened at $13.16 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.44. The stock has a market cap of $2.63 billion, a price-to-earnings ratio of -2.78, a PEG ratio of 0.82 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The business has a 50-day moving average price of $14.44 and a 200-day moving average price of $14.92.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. During the same period last year, the business posted $0.49 earnings per share. The company’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.9%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.